

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.35362009 |
| 2 | regulation of vitamin metabolic process (GO:0030656) | 4.98373284 |
| 3 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.90522831 |
| 4 | regulation of chronic inflammatory response (GO:0002676) | 4.54913524 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 4.51269744 |
| 6 | oligosaccharide catabolic process (GO:0009313) | 4.51230265 |
| 7 | myeloid dendritic cell differentiation (GO:0043011) | 4.47103156 |
| 8 | activation of MAPKKK activity (GO:0000185) | 4.33477746 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 4.27951091 |
| 10 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 4.24667878 |
| 11 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.20539498 |
| 12 | low-density lipoprotein particle clearance (GO:0034383) | 4.13362384 |
| 13 | regulation of podosome assembly (GO:0071801) | 4.11735965 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.01369329 |
| 15 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.99595949 |
| 16 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.98714828 |
| 17 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.92582020 |
| 18 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.84150928 |
| 19 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.80830728 |
| 20 | response to peptidoglycan (GO:0032494) | 3.79683430 |
| 21 | glycolipid catabolic process (GO:0019377) | 3.79661374 |
| 22 | regulation of cholesterol storage (GO:0010885) | 3.67351932 |
| 23 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.63956200 |
| 24 | positive regulation of heat generation (GO:0031652) | 3.59796801 |
| 25 | regulation of fever generation (GO:0031620) | 3.56708095 |
| 26 | myeloid dendritic cell activation (GO:0001773) | 3.51183399 |
| 27 | modulation by symbiont of host cellular process (GO:0044068) | 3.49047696 |
| 28 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.38345763 |
| 29 | regulation of immunoglobulin secretion (GO:0051023) | 3.38117746 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 3.36944769 |
| 31 | regulation of chemokine biosynthetic process (GO:0045073) | 3.29654971 |
| 32 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.23583908 |
| 33 | ceramide catabolic process (GO:0046514) | 3.17946754 |
| 34 | pinocytosis (GO:0006907) | 3.15920624 |
| 35 | germinal center formation (GO:0002467) | 3.15383118 |
| 36 | membrane lipid catabolic process (GO:0046466) | 3.14632090 |
| 37 | protein localization to endosome (GO:0036010) | 3.14347194 |
| 38 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.12531910 |
| 39 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.12215291 |
| 40 | sphingolipid catabolic process (GO:0030149) | 3.05248249 |
| 41 | response to protozoan (GO:0001562) | 3.04550064 |
| 42 | regulation of mononuclear cell migration (GO:0071675) | 3.04232020 |
| 43 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.02136536 |
| 44 | protein-lipid complex assembly (GO:0065005) | 3.01505163 |
| 45 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.97303419 |
| 46 | dendritic cell differentiation (GO:0097028) | 2.97255914 |
| 47 | T-helper 1 type immune response (GO:0042088) | 2.94541692 |
| 48 | plasma lipoprotein particle assembly (GO:0034377) | 2.94531612 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.92933781 |
| 50 | positive regulation of hair follicle development (GO:0051798) | 2.92871564 |
| 51 | positive regulation of hair cycle (GO:0042635) | 2.92871564 |
| 52 | regulation of early endosome to late endosome transport (GO:2000641) | 2.90356230 |
| 53 | adhesion of symbiont to host (GO:0044406) | 2.89989043 |
| 54 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.87163364 |
| 55 | regulation of RIG-I signaling pathway (GO:0039535) | 2.86159814 |
| 56 | monocyte chemotaxis (GO:0002548) | 2.84227307 |
| 57 | cellular response to lipopolysaccharide (GO:0071222) | 2.83818318 |
| 58 | negative regulation of amino acid transport (GO:0051956) | 2.83317603 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 2.82911001 |
| 60 | decidualization (GO:0046697) | 2.80189260 |
| 61 | type I interferon signaling pathway (GO:0060337) | 2.79167847 |
| 62 | cellular response to type I interferon (GO:0071357) | 2.79167847 |
| 63 | positive regulation of lipid storage (GO:0010884) | 2.74379309 |
| 64 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.74074147 |
| 65 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72775892 |
| 66 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.72680899 |
| 67 | response to type I interferon (GO:0034340) | 2.72580474 |
| 68 | regulation of superoxide anion generation (GO:0032928) | 2.70521678 |
| 69 | cellular response to virus (GO:0098586) | 2.70331801 |
| 70 | regulation of cholesterol homeostasis (GO:2000188) | 2.69885429 |
| 71 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.69519315 |
| 72 | cellular response to nicotine (GO:0071316) | 2.69489399 |
| 73 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.69366539 |
| 74 | defense response to protozoan (GO:0042832) | 2.67916873 |
| 75 | adhesion of symbiont to host cell (GO:0044650) | 2.66225833 |
| 76 | virion attachment to host cell (GO:0019062) | 2.66225833 |
| 77 | cellular response to molecule of bacterial origin (GO:0071219) | 2.65259979 |
| 78 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.64672869 |
| 79 | macrophage activation involved in immune response (GO:0002281) | 2.63135972 |
| 80 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.61813491 |
| 81 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.61100722 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.60302105 |
| 83 | positive regulation of interferon-alpha production (GO:0032727) | 2.59364461 |
| 84 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.59332247 |
| 85 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.59140719 |
| 86 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.58451714 |
| 87 | cellular response to arsenic-containing substance (GO:0071243) | 2.57616891 |
| 88 | response to thyroid hormone (GO:0097066) | 2.57388299 |
| 89 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.55734145 |
| 90 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.54905198 |
| 91 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.54871677 |
| 92 | positive regulation of extracellular matrix organization (GO:1903055) | 2.54772545 |
| 93 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.54614807 |
| 94 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.53929968 |
| 95 | osteoclast differentiation (GO:0030316) | 2.49644616 |
| 96 | regulation of response to interferon-gamma (GO:0060330) | 2.48261281 |
| 97 | T cell lineage commitment (GO:0002360) | 2.47452360 |
| 98 | negative regulation of insulin receptor signaling pathway (GO:0046627) | 2.46448714 |
| 99 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.45526030 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.45190492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.15512145 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.13375920 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83960014 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75089059 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.56709825 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 2.53485875 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.49031510 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.44563937 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.44017932 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27132743 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17295884 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09790597 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06146373 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97271886 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94040680 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94029405 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.93349307 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86135085 |
| 19 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85453444 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84737025 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84437687 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83427160 |
| 23 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.78459688 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77052941 |
| 25 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.67892138 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66671353 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66178700 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65870228 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61386713 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59814454 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57171480 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56698875 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55349978 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.54759841 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.50039543 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49681340 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44719110 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44508753 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38625134 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37906107 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37119372 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.35136220 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.32363734 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31934002 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30446115 |
| 46 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26886202 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26243788 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25147906 |
| 49 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24303005 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.23565811 |
| 51 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23311655 |
| 52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23152127 |
| 53 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21565439 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19782892 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19684542 |
| 56 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18205536 |
| 57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18065955 |
| 58 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17138429 |
| 59 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16060443 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15856688 |
| 61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.15485804 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15265706 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.14798450 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14036860 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13689491 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13338892 |
| 67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12786061 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12195341 |
| 69 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.12009559 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11799212 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11625344 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11530299 |
| 73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11302251 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10985884 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09883038 |
| 76 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.09825571 |
| 77 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09783597 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09716546 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09598260 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08538967 |
| 81 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08300033 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07655469 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07635339 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07618155 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07485801 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06719404 |
| 87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06556915 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05482171 |
| 89 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05238930 |
| 90 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04418645 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03714736 |
| 92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03343652 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03186727 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03058923 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02801446 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02708747 |
| 97 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02262467 |
| 98 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01640074 |
| 99 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01467376 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99826339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.40939569 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.41869307 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.70377767 |
| 4 | MP0005451_abnormal_body_composition | 3.62775945 |
| 5 | MP0004510_myositis | 3.39175812 |
| 6 | MP0009840_abnormal_foam_cell | 3.23991105 |
| 7 | MP0003436_decreased_susceptibility_to | 2.97026409 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.90550569 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.74498835 |
| 10 | MP0006082_CNS_inflammation | 2.55516151 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.49620664 |
| 12 | MP0009785_altered_susceptibility_to | 2.47615048 |
| 13 | MP0003075_altered_response_to | 2.21789676 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.17118717 |
| 15 | MP0001853_heart_inflammation | 2.14050240 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.10865046 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.09077805 |
| 18 | MP0009278_abnormal_bone_marrow | 2.07557443 |
| 19 | MP0004947_skin_inflammation | 2.02676020 |
| 20 | MP0000604_amyloidosis | 1.99193201 |
| 21 | MP0005387_immune_system_phenotype | 1.94306271 |
| 22 | MP0001790_abnormal_immune_system | 1.94306271 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.92788010 |
| 24 | MP0005025_abnormal_response_to | 1.82323089 |
| 25 | MP0005671_abnormal_response_to | 1.81344476 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.72336322 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.71172007 |
| 28 | MP0000858_altered_metastatic_potential | 1.69099791 |
| 29 | MP0002419_abnormal_innate_immunity | 1.66077284 |
| 30 | MP0000343_altered_response_to | 1.63527491 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.62407109 |
| 32 | MP0002254_reproductive_system_inflammat | 1.61759594 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.59225808 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.52611415 |
| 35 | MP0009764_decreased_sensitivity_to | 1.50093193 |
| 36 | MP0002723_abnormal_immune_serum | 1.46216407 |
| 37 | MP0005310_abnormal_salivary_gland | 1.45607732 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.45116280 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.42463291 |
| 40 | MP0003448_altered_tumor_morphology | 1.42419142 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.35985022 |
| 42 | MP0008469_abnormal_protein_level | 1.33896921 |
| 43 | MP0003329_amyloid_beta_deposits | 1.33175028 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.33086992 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.30588297 |
| 46 | MP0002089_abnormal_postnatal_growth/wei | 1.30349400 |
| 47 | MP0010307_abnormal_tumor_latency | 1.29143571 |
| 48 | MP0001800_abnormal_humoral_immune | 1.28930723 |
| 49 | MP0003123_paternal_imprinting | 1.28739241 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.28636348 |
| 51 | MP0002405_respiratory_system_inflammati | 1.25404146 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.23514051 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.23360700 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.23360700 |
| 55 | MP0003724_increased_susceptibility_to | 1.22735692 |
| 56 | MP0003195_calcinosis | 1.22241792 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.21355482 |
| 58 | MP0000685_abnormal_immune_system | 1.19894662 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.14938734 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.12226950 |
| 61 | MP0005166_decreased_susceptibility_to | 1.11884880 |
| 62 | MP0008004_abnormal_stomach_pH | 1.08520202 |
| 63 | MP0001819_abnormal_immune_cell | 1.07423012 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.06942671 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.04000431 |
| 66 | MP0003690_abnormal_glial_cell | 1.00957898 |
| 67 | MP0008260_abnormal_autophagy | 0.99532992 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 0.96250868 |
| 69 | MP0003091_abnormal_cell_migration | 0.95840119 |
| 70 | MP0006054_spinal_hemorrhage | 0.95230505 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.94915736 |
| 72 | MP0001849_ear_inflammation | 0.93213841 |
| 73 | MP0000609_abnormal_liver_physiology | 0.90431595 |
| 74 | MP0005365_abnormal_bile_salt | 0.90048008 |
| 75 | MP0004233_abnormal_muscle_weight | 0.89613459 |
| 76 | MP0000716_abnormal_immune_system | 0.87725682 |
| 77 | MP0000678_abnormal_parathyroid_gland | 0.87092318 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 0.85248407 |
| 79 | MP0004858_abnormal_nervous_system | 0.81249399 |
| 80 | MP0000920_abnormal_myelination | 0.80629787 |
| 81 | MP0001873_stomach_inflammation | 0.80243510 |
| 82 | MP0005647_abnormal_sex_gland | 0.79932597 |
| 83 | MP0001216_abnormal_epidermal_layer | 0.79857429 |
| 84 | MP0003693_abnormal_embryo_hatching | 0.79746583 |
| 85 | MP0002398_abnormal_bone_marrow | 0.77969213 |
| 86 | MP0005375_adipose_tissue_phenotype | 0.77264181 |
| 87 | MP0002429_abnormal_blood_cell | 0.77120159 |
| 88 | MP0003634_abnormal_glial_cell | 0.76123634 |
| 89 | MP0005023_abnormal_wound_healing | 0.74627478 |
| 90 | MP0003111_abnormal_nucleus_morphology | 0.74611735 |
| 91 | MP0000490_abnormal_crypts_of | 0.73837229 |
| 92 | MP0001915_intracranial_hemorrhage | 0.72017011 |
| 93 | MP0001727_abnormal_embryo_implantation | 0.71674198 |
| 94 | MP0008874_decreased_physiological_sensi | 0.71259598 |
| 95 | MP0005165_increased_susceptibility_to | 0.70872849 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.68336989 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.67743064 |
| 98 | MP0009763_increased_sensitivity_to | 0.65939167 |
| 99 | MP0002722_abnormal_immune_system | 0.59837124 |
| 100 | MP0005390_skeleton_phenotype | 0.58051645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.92501891 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.92501891 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.92501891 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.32298250 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.22855405 |
| 6 | Nuclear cataract (HP:0100018) | 4.06376349 |
| 7 | Deep venous thrombosis (HP:0002625) | 3.93221577 |
| 8 | Loss of speech (HP:0002371) | 3.90349317 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.88875953 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.86173848 |
| 11 | Disinhibition (HP:0000734) | 3.84063378 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.61847046 |
| 13 | Glomerulonephritis (HP:0000099) | 3.35970952 |
| 14 | Axonal loss (HP:0003447) | 3.17260088 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.16435219 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.13732905 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.10228029 |
| 18 | Apathy (HP:0000741) | 3.06657463 |
| 19 | Mutism (HP:0002300) | 2.97798477 |
| 20 | Metaphyseal irregularity (HP:0003025) | 2.93503772 |
| 21 | Diminished motivation (HP:0000745) | 2.87460920 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 2.82845139 |
| 23 | Optic neuritis (HP:0100653) | 2.82845139 |
| 24 | Increased serum ferritin (HP:0003281) | 2.82372206 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.82002808 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.82002808 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.82002808 |
| 28 | Neuronal loss in central nervous system (HP:0002529) | 2.77890821 |
| 29 | Orchitis (HP:0100796) | 2.77762202 |
| 30 | Mucopolysacchariduria (HP:0008155) | 2.74754572 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74754572 |
| 32 | Complement deficiency (HP:0004431) | 2.70624363 |
| 33 | Thin bony cortex (HP:0002753) | 2.69152056 |
| 34 | Purpura (HP:0000979) | 2.63086348 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 2.61634916 |
| 36 | Personality changes (HP:0000751) | 2.61335376 |
| 37 | Upper motor neuron abnormality (HP:0002127) | 2.50576475 |
| 38 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48640248 |
| 39 | Hyperparathyroidism (HP:0000843) | 2.45832928 |
| 40 | Abnormality of the lumbar spine (HP:0100712) | 2.44137556 |
| 41 | Progressive external ophthalmoplegia (HP:0000590) | 2.43927928 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.42249844 |
| 43 | Myocardial infarction (HP:0001658) | 2.37599089 |
| 44 | Achilles tendon contracture (HP:0001771) | 2.30372872 |
| 45 | Abnormality of complement system (HP:0005339) | 2.28165085 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.27795213 |
| 47 | Abnormality of the Achilles tendon (HP:0005109) | 2.25151321 |
| 48 | Hyperacusis (HP:0010780) | 2.24337145 |
| 49 | Multiple enchondromatosis (HP:0005701) | 2.22200734 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.19771739 |
| 51 | Dysphonia (HP:0001618) | 2.11705956 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.10205653 |
| 53 | Ragged-red muscle fibers (HP:0003200) | 2.08537003 |
| 54 | Bone pain (HP:0002653) | 2.08380482 |
| 55 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04531214 |
| 56 | Gangrene (HP:0100758) | 2.04320919 |
| 57 | Thoracic kyphosis (HP:0002942) | 2.03810038 |
| 58 | Dementia (HP:0000726) | 2.03676451 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.03066692 |
| 60 | Flat occiput (HP:0005469) | 2.02772651 |
| 61 | Abnormality of the thoracic spine (HP:0100711) | 2.02618962 |
| 62 | Delayed epiphyseal ossification (HP:0002663) | 2.02487256 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.00921739 |
| 64 | Myositis (HP:0100614) | 2.00162425 |
| 65 | Prolonged neonatal jaundice (HP:0006579) | 1.99704906 |
| 66 | Pathologic fracture (HP:0002756) | 1.98194442 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 1.98164703 |
| 68 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97510239 |
| 69 | Nausea (HP:0002018) | 1.97245232 |
| 70 | Abnormal trabecular bone morphology (HP:0100671) | 1.92438530 |
| 71 | Agnosia (HP:0010524) | 1.91369872 |
| 72 | Eczematoid dermatitis (HP:0000976) | 1.88755252 |
| 73 | Recurrent abscess formation (HP:0002722) | 1.87186628 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 1.86923031 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 1.86094489 |
| 76 | Inappropriate behavior (HP:0000719) | 1.85750137 |
| 77 | Hypercholesterolemia (HP:0003124) | 1.85662828 |
| 78 | Insomnia (HP:0100785) | 1.85464929 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84883779 |
| 80 | Amyloidosis (HP:0011034) | 1.84684948 |
| 81 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.81798008 |
| 82 | Zonular cataract (HP:0010920) | 1.79639696 |
| 83 | Increased IgM level (HP:0003496) | 1.75749127 |
| 84 | Hypertensive crisis (HP:0100735) | 1.75618254 |
| 85 | Xanthomatosis (HP:0000991) | 1.75479048 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 1.75388587 |
| 87 | Hepatosplenomegaly (HP:0001433) | 1.75199780 |
| 88 | Asymmetry of the thorax (HP:0001555) | 1.75169816 |
| 89 | Widely patent fontanelles and sutures (HP:0004492) | 1.73963723 |
| 90 | Progressive muscle weakness (HP:0003323) | 1.73766859 |
| 91 | Generalized aminoaciduria (HP:0002909) | 1.73190466 |
| 92 | Peripheral demyelination (HP:0011096) | 1.72798558 |
| 93 | Cupped ribs (HP:0000887) | 1.71728242 |
| 94 | Recurrent viral infections (HP:0004429) | 1.67426769 |
| 95 | Cholecystitis (HP:0001082) | 1.67142702 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 1.67142702 |
| 97 | Stomatitis (HP:0010280) | 1.63723289 |
| 98 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.61648520 |
| 99 | Parakeratosis (HP:0001036) | 1.59213777 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.58593270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.94479560 |
| 2 | NME2 | 5.47632138 |
| 3 | TAOK2 | 3.41912170 |
| 4 | ICK | 2.95116700 |
| 5 | PRPF4B | 2.71486350 |
| 6 | MAP3K14 | 2.66707053 |
| 7 | TRIB3 | 2.49401633 |
| 8 | DDR2 | 2.40462156 |
| 9 | RIPK1 | 2.38320538 |
| 10 | PIM2 | 2.34830432 |
| 11 | MAP3K11 | 2.28483319 |
| 12 | SMG1 | 2.14251205 |
| 13 | TAOK1 | 2.03836362 |
| 14 | FGFR4 | 1.94260446 |
| 15 | CDK12 | 1.90351674 |
| 16 | TYRO3 | 1.77394563 |
| 17 | LATS2 | 1.77058517 |
| 18 | MAP3K3 | 1.75439741 |
| 19 | MATK | 1.69054275 |
| 20 | TBK1 | 1.62507202 |
| 21 | SIK1 | 1.61898726 |
| 22 | GRK7 | 1.56762206 |
| 23 | EEF2K | 1.49270712 |
| 24 | ERN1 | 1.48603664 |
| 25 | MAP2K3 | 1.44586925 |
| 26 | IKBKB | 1.27410569 |
| 27 | MOS | 1.26806933 |
| 28 | FGR | 1.25911888 |
| 29 | ARAF | 1.25848079 |
| 30 | PDGFRA | 1.17819879 |
| 31 | IRAK4 | 1.17217229 |
| 32 | MAP3K1 | 1.15904235 |
| 33 | IRAK2 | 1.15553523 |
| 34 | MAP3K9 | 1.09024130 |
| 35 | CHUK | 1.06792921 |
| 36 | CDC42BPA | 1.05156019 |
| 37 | MAP3K13 | 1.01526652 |
| 38 | RIPK4 | 1.00012377 |
| 39 | ABL2 | 0.87277233 |
| 40 | MAP4K1 | 0.84018374 |
| 41 | TYK2 | 0.83579198 |
| 42 | SIK2 | 0.82285644 |
| 43 | CDK4 | 0.79370870 |
| 44 | IKBKE | 0.76843743 |
| 45 | CSK | 0.74499027 |
| 46 | TESK2 | 0.74254670 |
| 47 | MAP3K5 | 0.73581337 |
| 48 | PKN2 | 0.71003752 |
| 49 | MAP3K8 | 0.70148769 |
| 50 | BRAF | 0.68901599 |
| 51 | MAPK11 | 0.68184954 |
| 52 | CAMK1D | 0.68168813 |
| 53 | CDK6 | 0.68083132 |
| 54 | FGFR3 | 0.65070042 |
| 55 | JAK3 | 0.61499260 |
| 56 | PDPK1 | 0.61069823 |
| 57 | PAK4 | 0.60702164 |
| 58 | ALK | 0.60544399 |
| 59 | EPHA2 | 0.55197881 |
| 60 | BMPR2 | 0.55003008 |
| 61 | TGFBR2 | 0.54616991 |
| 62 | KSR2 | 0.51713360 |
| 63 | CLK1 | 0.50412139 |
| 64 | CDK15 | 0.49214778 |
| 65 | DYRK3 | 0.48024924 |
| 66 | BLK | 0.47255342 |
| 67 | CDK7 | 0.46561727 |
| 68 | BMX | 0.46376692 |
| 69 | CDK11A | 0.46303300 |
| 70 | TESK1 | 0.45307534 |
| 71 | MTOR | 0.43880464 |
| 72 | MAP2K6 | 0.43486846 |
| 73 | CDK14 | 0.43067451 |
| 74 | CDK18 | 0.42333703 |
| 75 | PDK1 | 0.41183548 |
| 76 | SIK3 | 0.40362166 |
| 77 | PBK | 0.38767799 |
| 78 | MST1R | 0.38448431 |
| 79 | IRAK1 | 0.37125323 |
| 80 | MAP3K10 | 0.36422896 |
| 81 | STK10 | 0.36338300 |
| 82 | PDK2 | 0.36279628 |
| 83 | HIPK2 | 0.34988640 |
| 84 | RPS6KC1 | 0.32889648 |
| 85 | RPS6KL1 | 0.32889648 |
| 86 | PIM1 | 0.31738539 |
| 87 | RPS6KA1 | 0.30808266 |
| 88 | DAPK1 | 0.30525624 |
| 89 | DYRK1B | 0.30454874 |
| 90 | MAPK4 | 0.28289961 |
| 91 | BUB1 | 0.27101183 |
| 92 | CSF1R | 0.26554597 |
| 93 | DAPK3 | 0.26537288 |
| 94 | JAK2 | 0.25258693 |
| 95 | AURKA | 0.23832976 |
| 96 | CHEK2 | 0.23747116 |
| 97 | RPS6KB2 | 0.22840510 |
| 98 | CAMKK1 | 0.22017826 |
| 99 | SCYL2 | 0.21687572 |
| 100 | MAPKAPK2 | 0.21145932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.85664094 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.92125322 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69814792 |
| 4 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.45598178 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.38854559 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.21415578 |
| 7 | Prion diseases_Homo sapiens_hsa05020 | 2.17091123 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13569162 |
| 9 | Bladder cancer_Homo sapiens_hsa05219 | 2.08368271 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.02035134 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95579925 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.94317743 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92362442 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.90629363 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.86880244 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76597756 |
| 17 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.74036821 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.73862573 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70625757 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65960962 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.62424491 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57391205 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56088293 |
| 24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55362707 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.52848271 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.49479556 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.42596656 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29109456 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.27995754 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.27959260 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27694824 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27085187 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27014488 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.24740679 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22968591 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.20220995 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16110578 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15530494 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.14595015 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13210339 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13044540 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11570486 |
| 43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06026458 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03713531 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03640894 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.03111202 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02822229 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01078094 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96033637 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94419813 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94240104 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93810907 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93509869 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89696278 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86805214 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86032776 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84872197 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83741510 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81274308 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79301504 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78506374 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77865001 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76093806 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73694379 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73281478 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72670206 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71459267 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70512400 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68741922 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.68696525 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68340092 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68147169 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68140733 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67925531 |
| 75 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67321003 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65461600 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64253100 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62158617 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58069162 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55557083 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55222307 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52619044 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50147885 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.49564527 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49261671 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48813372 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47181076 |
| 88 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47032314 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46011722 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43998977 |
| 91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43945418 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.43351946 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40962468 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40863400 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.40361195 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39777304 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39737224 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.39497354 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35412604 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34801890 |

